Memorial Sloan-Kettering Cancer Center at Commack is a clinical research site located in Commack, New York, United States 11725.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
Memorial Sloan-Kettering Cancer Center at Commack has participated in 18 clinical trials.
Therapeutic areas: Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer.
Sponsors: Memorial Sloan Kettering Cancer Center, Andrew B Lassman, MD.
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Memorial Sloan-Kettering Cancer Center at Commack has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Memorial Sloan-Kettering Cancer Center at Commack has 18 clinical trials on record. Their work covers Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer.
Yes — Memorial Sloan-Kettering Cancer Center at Commack holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.